![](/img/cover-not-exists.png)
Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIMEâCHF trial
Stöhr, Robert, Brandenburg, Vincent M., Heine, Gunnar H., Maeder, Micha T., Leibundgut, Gregor, Schuh, Alexander, Jeker, Urs, Pfisterer, Matthias, Sandersâvan Wijk, Sandra, Brunnerâla Rocca, HansLanguage:
english
Journal:
European Journal of Heart Failure
DOI:
10.1002/ejhf.1749
Date:
February, 2020
File:
PDF, 586 KB
english, 2020